Pediatric Perfusion Products Market

Pediatric Perfusion Products Market (Product: Pediatric Oxygenators, Pediatric Arterial Filters, Pediatric Cannulae, hemoconcentrators, Reservoirs, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Global Pediatric Perfusion Products Market Outlook 2031

  • The industry was valued at US$ 147.0 Mn in 2021
  • It is projected to advance at a CAGR of 7.3% from 2022 to 2031 and reach more than US$ 294.6 Mn by the end of 2031

Analysts’ Viewpoint

Congenital heart defects are structural abnormalities of the heart that are present at birth. Increase in the prevalence of congenital heart disease is driving the pediatric perfusion products market size.

Growth in the number of surgical procedures performed on children is expected to augment market progress during the forecast period. Several surgical procedures are becoming available for the treatment of a wider range of conditions in children, as medical technologies continue to advance.

Rise in awareness about heart abnormalities and related treatments is likely to offer lucrative growth opportunities for vendors in the market. Therefore, vendors are focused on the approval and launch of new products to expand their pediatric perfusion products market share.

Pediatric Perfusion Products Market

Market Introduction

Pediatric perfusion deals with the circulatory and respiratory needs of children during open-heart surgery. Pediatric perfusion devices are used to support the circulation and oxygenation of a child's blood during surgery. These devices ensure that the child's vital organs receive oxygen and nutrients during a surgical procedure.

Pediatric perfusion devices play a crucial role in the treatment of various congenital heart defects. These defects can range from mild to severe and can require surgical intervention. Heart-lung machines and oxygenators, blood pumps, cardiac monitors, and pediatric cannula are various types of pediatric perfusion products available in the industry.

Request a sample to get extensive insights into the Pediatric Perfusion Products Market

Increase in Prevalence of Congenital Heart Disease Contributing to Pediatric Perfusion Products Market Growth

Changes in individual genes or chromosomes can increase the risk of cardiac birth defects in children. Ventricular Septal Defect (VSD) is a common congenital heart defect in children. According to the Centers for Disease Control and Prevention (CDC), 16,800 infants in the U.S. are born with VSD.

Additionally, one million children suffer from congenital heart defects. This is anticipated to aid pediatric perfusion products market expansion in the near future.

Vendors in the industry are investing significantly in the R&D of pediatric perfusion technology. New products are being developed that offer better performance and more advanced features. These products can provide more effective support to children during surgical procedures.

In April 2021, LivaNova PLC received the U.S. Food and Drug Administration (FDA) 510(k) clearance for B-Capta, the new in-line, blood-gas monitoring system integrated into the market-leading S5 heart-lung machine. Thus, approval and launch of new products is estimated to fuel market statistics in the near future.

Rise in Adoption of Pediatric Cannulae

According to the latest market trends, the pediatric cannulae product segment is anticipated to hold largest share during the forecast period. This can be ascribed to increase in the prevalence of respiratory diseases in newborns and surge in preference for cannulae. Pediatric cannulae are soft and flexible, which make them suitable for neonatal use in high-flow oxygen therapy.

Request a custom report on Pediatric Perfusion Products Market

Surge in Demand for Cardiac Surgeries in Hospitals

The hospitals end-user segment held highest share of the market in 2021. The segment is expected to grow at a significant CAGR during the forecast period. Robust hospital infrastructure, increase in healthcare expenditure, and rise in the volume of surgeries due high prevalence of congenital heart diseases are driving the segment. Surge in the number of medical centers and operating rooms and high demand for cardiac surgeries are also fueling the segment.

Regional Outlook

According to the latest pediatric perfusion products market forecast, North America is projected to dominate the industry during 2022-2031. High prevalence of congenital heart diseases is driving market revenue in the region.

According to the CDC, congenital heart diseases affect approximately 1% of the total pediatric population in the U.S. each year. The prevalence of mild congenital heart diseases has increased in the country in the past five years, whereas the prevalence of severe congenital heart diseases has remained stable.

Increase in adoption of open heart surgeries, rise in the diagnosis rate of congenital heart diseases, and the presence of well-established healthcare infrastructure are also fueling pediatric perfusion products market development in North America.

According to the Cincinnati Children's Hospital Medical Center, more than 20,000 pediatric open heart surgeries are performed in the U.S. each year. The industry in Asia Pacific is projected to grow at the highest CAGR of 8.2% during the forecast period, owing to a large population of newborns and a surge in investment in the healthcare sector.

Analysis of Key Players

Major vendors in the industry have been profiled in the pediatric perfusion products market report based on parameters such as product portfolio, recent developments, financial overview, company overview, business strategies, and business segments.

These vendors include Medtronic, Terumo Cardiovascular Systems Corporation, LivaNova PLC, BL Lifesciences, Cardinal Health, Getinge AB, and Eurosets. These companies in the market are known for their high-quality products and innovative technologies.

Terumo Cardiovascular Systems Corporation is a global medical device company that offers a range of pediatric perfusion products, including heart-lung machines, oxygenators, and blood pumps. The company is known for its expertise in the field of pediatric perfusion. It is committed to improve pediatric care during surgery and invests significantly in the R&D of advanced products to achieve this goal.

Key Developments

  • In May 2020, LivaNova PLC received CE mark approval in Europe for its B-Capta system integrated into the S5 heart-lung machine

Pediatric Perfusion Products Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 147.0 Mn

Market Forecast Value in 2031

More than US$ 294.6 Mn

Compound Annual Growth Rate (CAGR)

7.3%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Mn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product
    • Pediatric Oxygenators
    • Pediatric Arterial Filters
    • Pediatric Cannulae
    • Hemoconcentrators
    • Reservoirs
    • Others
  • End-user
    • Hospitals
    • Specialty Clinics
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Medtronic
  • Terumo Cardiovascular Systems Corporation
  • LivaNova PLC
  • BL Lifesciences
  • Cardinal Health
  • Getinge AB
  • Eurosets

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global pediatric perfusion products market in 2021?

It stood at US$ 147.0 Mn in 2021

How big will the industry be by 2031?

It is projected to reach more than US$ 294.6 Mn by 2031

What will be the CAGR during the forecast period?

It is likely to be 7.3% from 2022 to 2031

Which are the prominent trends that affect business growth?

Increase in prevalence of congenital heart disease and growth in number of surgical procedures performed on children

Who are the prominent players in the market?

Medtronic, Terumo Cardiovascular Systems Corporation, LivaNova PLC, BL Lifesciences, Cardinal Health, Getinge AB, and Eurosets

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Pediatric Perfusion Products Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Definition

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Pediatric Perfusion Products Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Technological Advancements

        5.2. Regulatory Scenario

        5.3. COVID-19 Pandemic Impact on Industry

    6. Global Pediatric Perfusion Products Market Analysis and Forecast, by Product

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product, 2017–2031

            6.3.1. Pediatric Oxygenators

            6.3.2. Pediatric Arterial Filters

            6.3.3. Pediatric Cannulae

            6.3.4. Hemoconcentrators

            6.3.5. Reservoirs

            6.3.6. Others

        6.4. Market Attractiveness Analysis, by Product

    7. Global Pediatric Perfusion Products Market Analysis and Forecast, by End-user

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by End-user, 2017–2031

            7.3.1. Hospitals

            7.3.2. Speciality Clinics

            7.3.3. Others

        7.4. Market Attractiveness Analysis, by End-user

    8. Global Pediatric Perfusion Products Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Market Value Forecast, by Region

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. Market Attractiveness Analysis, by Region

    9. North America Pediatric Perfusion Products Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. Market Value Forecast, by Product, 2017–2031

            9.2.1. Pediatric Oxygenators

            9.2.2. Pediatric Arterial Filters

            9.2.3. Pediatric Cannulae

            9.2.4. Hemoconcentrators

            9.2.5. Reservoirs

            9.2.6. Others

        9.3. Market Value Forecast, by End-user, 2017–2031

            9.3.1. Hospitals

            9.3.2. Speciality Clinics

            9.3.3. Others

        9.4. Market Value Forecast, by Country, 2017–2031

            9.4.1. U.S.

            9.4.2. Canada

        9.5. Market Attractiveness Analysis

            9.5.1. By Product

            9.5.2. By End-user

            9.5.3. By Country

    10. Europe Pediatric Perfusion Products Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Product, 2017–2031

            10.2.1. Pediatric Oxygenators

            10.2.2. Pediatric Arterial Filters

            10.2.3. Pediatric Cannulae

            10.2.4. Hemoconcentrators

            10.2.5. Reservoirs

            10.2.6. Others

        10.3. Market Value Forecast, by End-user, 2017–2031

            10.3.1. Hospitals

            10.3.2. Speciality Clinics

            10.3.3. Others

        10.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Italy

            10.4.5. Spain

            10.4.6. Rest of Europe

        10.5. Market Attractiveness Analysis

            10.5.1. By Product

            10.5.2. By End-user

            10.5.3. By Country/Sub-region

    11. Asia Pacific Pediatric Perfusion Products Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product, 2017–2031

            11.2.1. Pediatric Oxygenators

            11.2.2. Pediatric Arterial Filters

            11.2.3. Pediatric Cannulae

            11.2.4. Hemoconcentrators

            11.2.5. Reservoirs

            11.2.6. Others

        11.3. Market Value Forecast, by End-user, 2017–2031

            11.3.1. Hospitals

            11.3.2. Speciality Clinics

            11.3.3. Others

        11.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Market Attractiveness Analysis

            11.5.1. By Product

            11.5.2. By End-user

            11.5.3. By Country/Sub-region

    12. Latin America Pediatric Perfusion Products Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product, 2017–2031

            12.2.1. Pediatric Oxygenators

            12.2.2. Pediatric Arterial Filters

            12.2.3. Pediatric Cannulae

            12.2.4. Hemoconcentrators

            12.2.5. Reservoirs

            12.2.6. Others

        12.3. Market Value Forecast, by End-user, 2017–2031

            12.3.1. Hospitals

            12.3.2. Speciality Clinics

            12.3.3. Others

        12.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America

        12.5. Market Attractiveness Analysis

            12.5.1. By Product

            12.5.2. By End-user

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Pediatric Perfusion Products Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product, 2017–2031

            13.2.1. Pediatric Oxygenators

            13.2.2. Pediatric Arterial Filters

            13.2.3. Pediatric Cannulae

            13.2.4. Hemoconcentrators

            13.2.5. Reservoirs

            13.2.6. Others

        13.3. Market Value Forecast, by End-user, 2017–2031

            13.3.1. Hospitals

            13.3.2. Speciality Clinics

            13.3.3. Others

        13.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Market Attractiveness Analysis

            13.5.1. By Product

            13.5.2. By End-user

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player – Competition Matrix (By Tier and Size of Companies)

        14.2. Market Share Analysis, by Company (2021)

        14.3. Company Profiles

            14.3.1. Medtronic

                14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.1.2. Product Portfolio

                14.3.1.3. SWOT Analysis

                14.3.1.4. Strategic Overview

            14.3.2. Terumo Cardiovascular Systems Corporation

                14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.2.2. Product Portfolio

                14.3.2.3. SWOT Analysis

                14.3.2.4. Strategic Overview

            14.3.3. LivaNova PLC

                14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.3.2. Product Portfolio

                14.3.3.3. SWOT Analysis

                14.3.3.4. Strategic Overview

            14.3.4. BL Lifesciences

                14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.4.2. Product Portfolio

                14.3.4.3. SWOT Analysis

                14.3.4.4. Strategic Overview

            14.3.5. Cardinal Health

                14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.5.2. Product Portfolio

                14.3.5.3. SWOT Analysis

                14.3.5.4. Strategic Overview

            14.3.6. Getinge AB

                14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.6.2. Product Portfolio

                14.3.6.3. SWOT Analysis

                14.3.6.4. Strategic Overview

            14.3.7. Eurosets

                14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.7.2. Product Portfolio

                14.3.7.3. SWOT Analysis

                14.3.7.4. Strategic Overview

    List of Tables

    Table 01: Global Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 02: Global Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 03: Global Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 04: North America Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 05: North America Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 06: North America Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 07: Europe Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 08: Europe Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 09: Europe Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Asia Pacific Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 11: Asia Pacific Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 12: Asia Pacific Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 13: Latin America Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 14: Latin America Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 15: Latin America Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 16: Middle East & Africa Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 17: Middle East & Africa Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 18: Middle East & Africa Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    List of Figures

    Figure 01: Global Pediatric Perfusion Products Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Global Pediatric Perfusion Products Market Analysis and Forecast, by Product, 2021 and 2031

    Figure 03: Global Pediatric Perfusion Products Market Attractiveness Analysis, by Product, 2022–2031

    Figure 04: Global Pediatric Perfusion Products Market Analysis and Forecast, by End-user, 2021 and 2031

    Figure 05: Global Pediatric Perfusion Products Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 06: Global Pediatric Perfusion Products Market Analysis and Forecast, by Region, 2021 and 2031

    Figure 07: Global Pediatric Perfusion Products Market Attractiveness Analysis, by Region, 2022–2031

    Figure 08: North America Pediatric Perfusion Products Market Value (US$ Mn) Forecast, 2017–2031

    Figure 09: North America Pediatric Perfusion Products Market Analysis and Forecast, by Product, 2021 and 2031

    Figure 10: North America Pediatric Perfusion Products Market Attractiveness Analysis, by Product, 2022–2031

    Figure 11: North America Pediatric Perfusion Products Market Analysis and Forecast, by End-user, 2021 and 2031

    Figure 12: North America Pediatric Perfusion Products Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 13: North America Pediatric Perfusion Products Market Analysis and Forecast, by Country, 2021 and 2031

    Figure 14: North America Pediatric Perfusion Products Market Attractiveness Analysis, by Country, 2022–2031

    Figure 15: Europe Pediatric Perfusion Products Market Value (US$ Mn) Forecast, 2017–2031

    Figure 16: Europe Pediatric Perfusion Products Market Analysis and Forecast, by Product, 2021 and 2031

    Figure 17: Europe Pediatric Perfusion Products Market Attractiveness Analysis, by Product, 2022–2031

    Figure 18: Europe Pediatric Perfusion Products Market Analysis and Forecast, by End-user, 2021 and 2031

    Figure 19: Europe Pediatric Perfusion Products Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 20: Europe Pediatric Perfusion Products Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031

    Figure 21: Europe Pediatric Perfusion Products Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 22: Asia Pacific Pediatric Perfusion Products Market Value (US$ Mn) Forecast, 2017–2031

    Figure 23: Asia Pacific Pediatric Perfusion Products Market Analysis and Forecast, by Product, 2021 and 2031

    Figure 24: Asia Pacific Pediatric Perfusion Products Market Attractiveness Analysis, by Product, 2022–2031

    Figure 25: Asia Pacific Pediatric Perfusion Products Market Analysis and Forecast, by End-user, 2021 and 2031

    Figure 26: Asia Pacific Pediatric Perfusion Products Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 27: Asia Pacific Pediatric Perfusion Products Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031

    Figure 28: Asia Pacific Pediatric Perfusion Products Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 29: Latin America Pediatric Perfusion Products Market Value (US$ Mn) Forecast, 2017–2031

    Figure 30: Latin America Pediatric Perfusion Products Market Analysis and Forecast, by Product, 2021 and 2031

    Figure 31: Latin America Pediatric Perfusion Products Market Attractiveness Analysis, by Product, 2022–2031

    Figure 32: Latin America Pediatric Perfusion Products Market Analysis and Forecast, by End-user, 2021 and 2031

    Figure 33: Latin America Pediatric Perfusion Products Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 34: Latin America Pediatric Perfusion Products Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031

    Figure 35: Latin America Pediatric Perfusion Products Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 36: Middle East & Africa Pediatric Perfusion Products Market Value (US$ Mn) Forecast, 2017–2031

    Figure 37: Middle East & Africa Pediatric Perfusion Products Market Analysis and Forecast, by Product, 2021 and 2031

    Figure 38: Middle East & Africa Pediatric Perfusion Products Market Attractiveness Analysis, by Product, 2022–2031

    Figure 39: Middle East & Africa Pediatric Perfusion Products Market Analysis and Forecast, by End-user, 2021 and 2031

    Figure 40: Middle East & Africa Pediatric Perfusion Products Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 41: Middle East & Africa Pediatric Perfusion Products Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031

    Figure 42: Middle East & Africa Pediatric Perfusion Products Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 43: Global Pediatric Perfusion Products Market Share Analysis/Ranking, by Company, 2021

Copyright © Transparency Market Research, Inc. All Rights reserved